CTI BioPharma Corp is a biopharmaceutical company based in Seattle, Washington, focused on developing and commercializing targeted therapies for blood-related cancers. Founded in 1991 and originally named Cell Therapeutics, Inc., the company rebranded in 2014 and became a commercial-stage entity specializing in rare blood cancers. In June 2023, CTI BioPharma was acquired by Swedish Orphan Biovitru...